FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Valsartan Tablets 320 mg Recall

Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Prefer…

Preferred Pharmaceuticals, Inc · Anaheim, CA

Risk level
Class II
Reported by FDA
Aug 29, 2018
Recall ID
D-1107-2018
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Valsartan Tablets 320 mg starting Aug 15, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1107-2018 on Aug 29, 2018. Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Status: Terminated.

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Product description

Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9

Lot numbers, UPCs & expiration codes

Lot # G2017F NDC 68788-6882-9

Where it was sold

Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1107-2018
Classification
Class II
Status
Terminated
Recall initiated
Aug 15, 2018
FDA report date
Aug 29, 2018
Quantity
9 bottles consisting of 90 tables each bottle
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc

Original FDA data

Every field from FDA enforcement report D-1107-2018, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
80840
Address
1250 N Lakeview Ave Ste O
Code information
Lot # G2017F NDC 68788-6882-9
Postal code
92807-1801
Report date
Aug 29, 2018
Product type
Drugs
Recall number
D-1107-2018
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc
Product quantity
9 bottles consisting of 90 tables each bottle
Termination date
Jan 18, 2019
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9
Distribution pattern
Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.
Recall initiation date
Aug 15, 2018
Initial firm notification
Letter
Center classification date
Aug 17, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1107-2018, published Aug 29, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls